Lower-than-standard dose peg-IFN alfa-2a for chronic hepatitis C caused by genotype 2 and 3 is sufficient when given in combination with weight-based ribavirin

Weight affect relapse rates in latinos w

Weight affect relapse rates in latinos with genotype 2/3 chronic hepatitis C (CHC) treated with peg IFN alfa-2a (Pegasys) 180 mcg/week and 800 mg daily of ribavirin for 24 weeks

✍ Maribel Rodríguez-Torres; Carlos F. Ríos-Bedoya; Grisell Ortiz-Lasanta; Dagmary 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

## Abstract Efficacy of chronic hepatitis C (CHC) treatment with Peg‐IFN and Ribavirin (RBV) is superior for genotypes 2/3 (GT‐2/3) than for genotype 1 (GT‐1) patients. Efficacy of treatment in Latinos infected with GT‐2/3 is unknown. The purpose of the study was to examine efficacy of Peg‐IFN/RBV